BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22818151)

  • 21. [Low dose brachytherapy with seeds--an interdisciplinary therapy alternative to radical prostatectomy].
    Kahmann F; Henkel T
    Praxis (Bern 1994); 2001 Sep; 90(36):1523-31. PubMed ID: 11593908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brachytherapy and radical prostatectomy in patients with early prostate cancer.
    Ferreira AS; Guerra MR; Lopes HE; Lima UT; Vasconcelos YA; Teixeira MT
    Rev Assoc Med Bras (1992); 2015; 61(5):431-9. PubMed ID: 26603006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current controversies in the treatment of localized prostate cancer].
    Bischoff R; Chaloupka M; Westhofen T; Grimm T; Schlenker B; Weinhold P; Tilki D; Stief CG; Kretschmer A
    Urologe A; 2019 May; 58(5):524-528. PubMed ID: 30859231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triple treatment of high-risk prostate cancer. A matched cohort study with up to 19 years follow-up comparing survival outcomes after triple treatment and treatment with hormones and radiotherapy.
    Gunnarsson O; Schelin S; Brudin L; Carlsson S; Damber JE
    Scand J Urol; 2019; 53(2-3):102-108. PubMed ID: 30990112
    [No Abstract]   [Full Text] [Related]  

  • 25. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease.
    Heidenreich A; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Mottet N; Schmid HP; van der Kwast T; Wiegel T; Zattoni F;
    Eur Urol; 2011 Jan; 59(1):61-71. PubMed ID: 21056534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cryotherapy for localised prostate cancer.
    Shelley M; Wilt TJ; Coles B; Mason MD
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005010. PubMed ID: 17636783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of prostate cancer: watchful waiting, radical prostatectomy, and cryoablation.
    Drachenberg DE
    Semin Surg Oncol; 2000; 18(1):37-44. PubMed ID: 10617895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of Localised Prostate Cancer in Kidney Transplant Patients: A Systematic Review from the EAU Guidelines on Renal Transplantation Panel.
    Hevia V; Boissier R; Rodríguez-Faba Ó; Fraser-Taylor C; Hassan-Zakri R; Lledo E; Regele H; Buddde K; Figueiredo A; Olsburgh J; Breda A
    Eur Urol Focus; 2018 Mar; 4(2):153-162. PubMed ID: 29921544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Practice guideline 'Prostate cancer: diagnosis and treatment'].
    de Reijke TM; Battermann JJ; van Moorselaar RJ; de Jong IJ; Visser AP; Burgers JS
    Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1771-5. PubMed ID: 18754308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radical prostatectomy vs radiation therapy and androgen-suppression therapy in high-risk prostate cancer.
    Westover K; Chen MH; Moul J; Robertson C; Polascik T; Dosoretz D; Katin M; Salenius S; D'Amico AV
    BJU Int; 2012 Oct; 110(8):1116-21. PubMed ID: 22540922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localized and Locally Advanced Prostate Cancer: Treatment Options.
    Achard V; Panje CM; Engeler D; Zilli T; Putora PM
    Oncology; 2021; 99(7):413-421. PubMed ID: 33784675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer.
    Wolff RF; Ryder S; Bossi A; Briganti A; Crook J; Henry A; Karnes J; Potters L; de Reijke T; Stone N; Burckhardt M; Duffy S; Worthy G; Kleijnen J
    Eur J Cancer; 2015 Nov; 51(16):2345-67. PubMed ID: 26254809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brachytherapy for prostate cancer: a systematic review of clinical and cost effectiveness.
    Norderhaug I; Dahl O; Høisaeter PA; Heikkilä R; Klepp O; Olsen DR; Kristiansen IS; Waehre H; Bjerklund Johansen TE
    Eur Urol; 2003 Jul; 44(1):40-6. PubMed ID: 12814673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A retrospective study of the treatment of locally advanced prostate cancer by six institutions in eastern and north-eastern Japan.
    Hachiya T; Akakura K; Saito S; Shinohara N; Sato K; Harada M; Kato T; Okada K
    BJU Int; 2005 Mar; 95(4):534-40. PubMed ID: 15705075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation.
    Stokes SH
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):129-36. PubMed ID: 10758314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recommendations for the treatment of localized prostate cancer by permanent interstitial brachytherapy.
    Hakenberg OW; Wirth MP; Hermann T; Alken P; Kovacs G; Müller RP; Ahlemann L; Schalkhäuser K
    Urol Int; 2003; 70(1):15-20. PubMed ID: 12566809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does brachytherapy have a role in the treatment of prostate cancer?
    Grimm PD; Blasko JC; Ragde H; Sylvester J; Clarke D
    Hematol Oncol Clin North Am; 1996 Jun; 10(3):653-73. PubMed ID: 8773503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study.
    Mazariego CG; Egger S; King MT; Juraskova I; Woo H; Berry M; Armstrong BK; Smith DP
    BMJ; 2020 Oct; 371():m3503. PubMed ID: 33028540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer.
    Kupelian PA; Potters L; Khuntia D; Ciezki JP; Reddy CA; Reuther AM; Carlson TP; Klein EA
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):25-33. PubMed ID: 14697417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Permanent 125I-seed brachytherapy or radical prostatectomy: a prospective comparison considering oncological and quality of life results.
    Borchers H; Kirschner-Hermanns R; Brehmer B; Tietze L; Reineke T; Pinkawa M; Eble MJ; Jakse G
    BJU Int; 2004 Oct; 94(6):805-11. PubMed ID: 15476513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.